Taipei, Taiwan YFY Biotech Management Company appeared to be the VC, which was created in 2003. The leading representative office of defined VC is situated in the Taipei. The company was established in Asia in Taiwan.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline TaiGen Biotechnology, Elixir Pharmaceuticals, Nereus Pharmaceuticals The fund has no exact preference in a number of founders of portfolio startups. When startup sums 2 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Test and Measurement, Medical. For fund there is a match between the location of its establishment and the land of its numerous investments - Taiwan.
This YFY Biotech Management Company works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2006. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2007.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the YFY Biotech Management Company, startups are often financed by China Development Industrial Bank (CDIB), Pacific Venture Group, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are Taiwan Development Fund, MPM Capital, YFY Inc.. In the next rounds fund is usually obtained by Taiwan Development Fund, Roche Venture Fund, Physic Ventures.
Besides them, we counted 1 critical employee of this fund in our database.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Argonaut Holdings | Detroit, Michigan, United States |
| Blueprint Capital Advisors | New York, New York, United States |
| CROOZ | Japan, Shinagawa |
| Cyber Wisdom | China, Hong Kong, Kowloon |
| Fairstead | New York, New York, United States |
| Goodworks Ventures | Missoula, Montana, United States |
| Guanhui Shiji | Beijing, Beijing, China |
| K50 | New York, New York, United States |
| Lerner Enterprises | Maryland, Rockville, United States |
| Million Tons Capital | China, Shanghai |
| Mingyin Guoji Ziben Touzi | Beijing, Beijing, China |
| Phil Company | Japan, Tokyo |
| Santen Pharmaceutical | California, Emeryville, United States |
| Source-Israel | Hefa, Israel, Tirat Carmel |
| Southern Cross Group | Argentina, Buenos Aires, Distrito Federal |
| Spiral Capital | Chiyoda, Japan |
| Steel Partners Holdings L.P. | New York, New York, United States |
| Tianjin Deya Touzi | - |
| Yongfeng Machinery | China, Jimo, Shandong |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TaiMed Biologics | $22M | 31 Mar 2010 | New Taipei, Taiwan | ||
TaiGen Biotechnology | $37M | 01 Jan 2009 | New Taipei, Taiwan | ||
| $10M | 21 Dec 2006 | Taiwan, New Taipei | |||
Elixir Pharmaceuticals | $31M | 27 Nov 2006 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TaiMed Biologics | $22M | 31 Mar 2010 | New Taipei, Taiwan | ||
TaiGen Biotechnology | $37M | 01 Jan 2009 | New Taipei, Taiwan | ||
| $10M | 21 Dec 2006 | Taiwan, New Taipei | |||
Elixir Pharmaceuticals | $31M | 27 Nov 2006 | Cambridge, Massachusetts, United States |
